Literature DB >> 28436700

An Approach to the Evaluation of Incidentally Identified Bone Lesions Encountered on Imaging Studies.

Stephanie Bernard1, Eric Walker1, Meera Raghavan2,3.   

Abstract

OBJECTIVE: This article discusses the strengths and weaknesses of the various anatomic and molecular imaging techniques in the evaluation of unexpected bone lesions.
CONCLUSION: An approach to the imaging evaluation of chondroid, osteoblastic, and osteolytic lesions as well as focal marrow abnormalities is reviewed.

Entities:  

Keywords:  bone lesion; incidental finding; osteoblastic; osteolytic; unexpected

Mesh：

Year:  2017        PMID： 28436700     DOI： 10.2214/AJR.16.17434

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN： 0361-803X            Impact factor:   3.959


  12 in total

Review 1.  Sclerotic bone lesions caused by non-infectious and non-neoplastic diseases: a review of the imaging and clinicopathologic findings.

Authors:  Vaibhav Gulati; Majid Chalian; Jaehyuck Yi; Uma Thakur; Avneesh Chhabra
Journal:  Skeletal Radiol       Date:  2020-10-11       Impact factor: 2.199

Review 2.  Bone and soft tissue tumors at the borderlands of malignancy.

Authors:  Julia Crim; Lester J Layfield
Journal:  Skeletal Radiol       Date:  2022-06-29       Impact factor: 2.199

3.  Bone lesions on baseline staging rectal MRI: prevalence and significance in patients with rectal adenocarcinoma.

Authors:  Jeffrey Levine; Iva Petkovska; Jonathan Landa; David D B Bates; Marinela Capanu; J Louis Fuqua; Viktoriya Paroder; Junting Zheng; Marc J Gollub; Jennifer S Golia Pernicka
Journal:  Abdom Radiol (NY)       Date:  2021-02-04

Review 4.  Society of Skeletal Radiology- white paper. Guidelines for the diagnostic management of incidental solitary bone lesions on CT and MRI in adults: bone reporting and data system (Bone-RADS).

Authors:  Connie Y Chang; Hillary W Garner; Shivani Ahlawat; Behrang Amini; Matthew D Bucknor; Jonathan A Flug; Iman Khodarahmi; Michael E Mulligan; Jeffrey J Peterson; Geoffrey M Riley; Mohammad Samim; Santiago A Lozano-Calderon; Jim S Wu
Journal:  Skeletal Radiol       Date:  2022-03-28       Impact factor: 2.128

5.  Validity of negative bone biopsy in suspicious bone lesions.

Authors:  Mine B Lange; Lars J Petersen; Michael B Nielsen; Helle D Zacho
Journal:  Acta Radiol Open       Date:  2021-07-27

6.  Diagnosis of bone metastases in breast cancer: Lesion-based sensitivity of dual-time-point FDG-PET/CT compared to low-dose CT and bone scintigraphy.

Authors:  Jeanette Ansholm Hansen; Mohammad Naghavi-Behzad; Oke Gerke; Christina Baun; Kirsten Falch; Sandra Duvnjak; Abass Alavi; Poul Flemming Høilund-Carlsen; Malene Grubbe Hildebrandt
Journal:  PLoS One       Date:  2021-11-18       Impact factor: 3.240

Review 7.  Mimickers of Hill-Sachs Lesions [Formula: see text].

Authors:  Allison Herring; Derik L Davis
Journal:  Can Assoc Radiol J       Date:  2020-02-06       Impact factor: 2.248

8.  An international expert opinion statement on the utility of PET/MR for imaging of skeletal metastases.

Authors:  Jad S Husseini; Bárbara Juarez Amorim; Angel Torrado-Carvajal; Vinay Prabhu; David Groshar; Lale Umutlu; Ken Herrmann; Lina García Cañamaque; José Ramón García Garzón; William E Palmer; Pedram Heidari; Tiffany Ting-Fang Shih; Jacob Sosna; Cristina Matushita; Juliano Cerci; Marcelo Queiroz; Valdair Francisco Muglia; Marcello H Nogueira-Barbosa; Ronald J H Borra; Thomas C Kwee; Andor W J M Glaudemans; Laura Evangelista; Marco Salvatore; Alberto Cuocolo; Andrea Soricelli; Christian Herold; Andrea Laghi; Marius Mayerhoefer; Umar Mahmood; Ciprian Catana; Heike E Daldrup-Link; Bruce Rosen; Onofrio A Catalano
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-02-22       Impact factor: 9.236

9.  Enostosis-related epilepsy.

Authors:  Jorge Vaz Lourenço; Joana Coelho; Andrea Salgueiro
Journal:  BJR Case Rep       Date:  2021-01-07

10.  Prostate adenocarcinoma with osteolytic metastases: Case report and review of the literature.

Authors:  Keaton Rummel; John Benson; Luke Roller
Journal:  Radiol Case Rep       Date:  2021-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.